Advertisement

Topics

Sandoz’s Erelzi available for multiple inflammatory disease treatment in Canada

19:00 EDT 21 Aug 2017 | Pharmaceutical Technology

Novartis division Sandoz has made its Erelzi (etanercept) therapy available for the treatment of multiple inflammatory diseases for patients in Canada.

Original Article: Sandoz’s Erelzi available for multiple inflammatory disease treatment in Canada

NEXT ARTICLE

More From BioPortfolio on "Sandoz’s Erelzi available for multiple inflammatory disease treatment in Canada"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...